EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations

Arabella Simpkin, Elaine Cochran, Fergus Cameron, Mehul Dattani, Martin de Bock, David B Dunger, Gun Forsander, Tulay Guran, Julie Harris, Iona Isaac, Khalid Hussain, Robert Kleta und 8 weitere

Nephron Physiology · 24.10.2014 · 128 (3-4) · 55-61

DOI: 10.1159/000366225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron Physiology, online erschienen am 24.10.2014. Verfasst von Arabella Simpkin und 19 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Medical Research Council, Wellcome Trust, Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Donohue and Rabson-Mendenhall syndrome are rare autosomal recessive disorders caused by mutations in the insulin receptor gene, INSR. Phenotypic features include extreme insulin resistance, linear growth retardation, paucity of fat and muscle, and soft tissue overgrowth. The insulin receptor is also expressed in the kidney, where animal data suggest it plays a role in glomerular function and blood pressure (BP) regulation, yet such a role in the human kidney is untested. Patients with biallelic INSR mutations provide a rare opportunity to ascertain its role in man.

Methods

Retrospective review of patients with INSR mutations. Data for BP, renal imaging, plasma creatinine and electrolyte levels, as well as urine protein, albumin and calcium excretion were sought from the treating clinicians.

Results

From 33 patients with INSR mutations, data were available for 17 patients. Plasma creatinine was low (mean ± SD: 25 ± 9 μmol/l) and mean plasma electrolyte concentrations were within the normal range (n = 13). Systolic BP ranged between the 18th and 91st percentile for age, sex, height and weight (n = 9; mean ± SD: 49 ± 24). Twenty-four-hour urinary calcium data were available from 10 patients and revealed hypercalciuria in all (mean ± SD: 0.32 ± 0.17 mmol/kg/day; normal

Schlagwörter

Stichwörter der Autor:innen

Donohue syndromeHypercalciuriaINSRInsulin receptorLeprechaunismNephrocalcinosisRabson-Mendenhall syndrome

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Department of Health

Zitieren

APA

Simpkin, A., Cochran, E., Cameron, F., Dattani, M., de Bock, M., Dunger, D. B., Forsander, G., Guran, T., Harris, J., Isaac, I., Hussain, K., Kleta, R., Peters, C., Tasic, V., Williams, R., Yap Kok Peng, F., O''Rahilly, S., Gorden, P., Semple, R. K., & Bockenhauer, D. (2014). Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiology, 128(3-4), 55-61. https://doi.org/10.1159/000366225

Vancouver

Simpkin A, Cochran E, Cameron F, Dattani M, de Bock M, Dunger DB, et al. Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiology. 2014;128(3-4):55-61. doi:10.1159/000366225

BibTeX
@article{Simpkin2014,
  author = {Simpkin, Arabella and Cochran, Elaine and Cameron, Fergus and Dattani, Mehul and de Bock, Martin and Dunger, David B and Forsander, Gun and Guran, Tulay and Harris, Julie and Isaac, Iona and Hussain, Khalid and Kleta, Robert and Peters, Catherine and Tasic, Velibor and Williams, Rachel and Yap Kok Peng, Fabian and O''Rahilly, Stephan and Gorden, Philipp and Semple, Robert K and Bockenhauer, Detlef},
  title = {Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations},
  journal = {Nephron Physiology},
  year = {2014},
  volume = {128},
  number = {3-4},
  pages = {55--61},
  doi = {10.1159/000366225}
}
Kostenlos starten →